Stockreport

LENZ Therapeutics to Report First Quarter Financial Results and Business Update on May 8, 2024

LENZ Therapeutics, Inc.  (LENZ) 
PDF SAN DIEGO, May 01, 2024 (GLOBE NEWSWIRE) -- LENZ Therapeutics, Inc. (Nasdaq: LENZ or “LENZ” or the “Company”), a late clinical-stage biopharmaceutical company focused [Read more]